Rice University research shows the harmful impact of myths regarding motherhood, education, and professional agency. Photo via Getty Images

Gender wage discrimination remains a stubborn problem in the United States. On average, women are paid only 80 cents for every dollar paid to non-Hispanic white men, and far greater gaps persist for Latina, Black, and Native American women. Despite progress in recent decades, we have a long way to go on this issue. At the current rate, pay inequity will persist until the distant year of 2152.

What keeps us from bridging the wage gap?

In a peer-reviewed commentary regarding research that examines workplace victim-blaming, Rice University professor Mikki Hebl and former Rice Ph.D. students Shannon Cheng, Abigail Corrington, Linnea Ng and Ivy Watson interrogate the role victim-blaming plays in perpetuating the gender wage gap. According to Hebl and her team, harmful myths regarding women’s relation to the workplace cloud our understanding of why the wage gap exists to begin with. To combat the problem, they say, we must first identify and debunk such misconceptions. And then, organizational leaders must take tangible steps to implement nondiscriminatory practices.

Here are a few of the victim-blaming myths Hebl and her team attribute to the persisting gender wage gap:

Myth: Motherhood drives women to leave the workforce.

This idea doesn’t hold up under scrutiny. In 44 percent of families, women are breadwinners, and 75 percent of single mothers are sole breadwinners. On top of workplace labor, women also spend more time on service-related activities than men and an average of 65 more minutes per day on childcare and household maintenance. Moreover, mothers often face forms of workplace discrimination that fathers simply do not. The more prominent causes of women’s decision to exit are unrelated to motherhood, such as limited career opportunities and unsatisfying work environments.

Myth: Women work in less lucrative professions.

There certainly are male and female-dominated industries. But this myth suggests that women willingly opt for lower-paying careers. It also implies that some professions do not have a problem with wage inequity. But the pay gap persists across professions, and at every level. Even in female-dominated professions, women are paid less than men who share the same level of experience.

Myth: Women don’t have as much education or experience as men, and they don’t ask for what they want.

Women now hold more college and graduate degrees than men, but they continue earning less. And as women and men gain career experience, the gender pay gap widens. Indeed, the gap is largest at the executive level. In terms of women’s experience with promotions and salary increases, stereotypes and gender biases make it challenging for them to secure equal pay for equal work. Men and women are both inclined to ask for what they want, but salary negotiations often do not yield the same results for women as for men.

Victim-blaming myths like these prevent us from making progress on the issue of pay inequity. We must actively debunk them. But just as importantly, researchers argue, company leaders must put energy and resources toward addressing the problem.

Beyond deflating misconceptions about women and work, how can we change the status quo? Based on research, Hebl and her team offer these actionable strategies and suggestions:

  • Identify and remove barriers to pay equity (e.g., hold focus groups with women in the organization).
  • Provide equal growth opportunities (e.g., offer equal access to mentorship).
  • Strive toward work/life balance (e.g., subsidize or create on-site childcare).
  • Ensure nondiscriminatory policies (e.g., publish compensation ranges).
  • Promote male allyship (e.g., men in positions of influence advocate for equity).

This final strategy stands out as perhaps the most intriguing. It seems obvious to implement nondiscriminatory policies like transparency about promotion criteria. Such policies are essential for bridging the wage gap and building a culture of trust.

But what role, according to research, do male allies play in effecting a major societal and organizational change? At the very least, men can help debunk the myths that Hebl et al. describe. But more importantly, research shows that men are more likely to support gender causes when championed by other men. Male allies have immense power in advancing the cause of gender equality, which means their involvement is not just welcome but essential in the pursuit to make one dollar for men equal one dollar for women.

------

This article originally ran on Rice Business Wisdom and was based on research from Michelle "Mikki" Hebl, the Martha and Henry Malcolm Lovett Chair of Psychology at Rice University and a professor of management at Jones Graduate School of Business.

Academics have learned quickly that investigations based on data from online research agencies can have problems. Here are those problems and alternatives, according to Rice University researchers. Photo via Getty Images

Rice research: Revisiting the merits of nondigital data collecting

houston voices

Academics are learning quickly that investigations based on data from online research agencies have their drawbacks. Thousands of such studies are released every year – and if the data is compromised, so too are the studies themselves.

So it’s natural for researchers, and the managers who rely on their findings, to be concerned about potential problems with the samples they’re studying. Among them: participants who aren’t in the lab and researchers who can’t see who is taking their survey, what they are doing while answering questions or even if they are who they claim to be online. In the wake of a 2018 media piece about Amazon’s Mechanical Turks Service, “Bots on Amazon’s MTurk Are Ruining Psychology Studies,” one psychology professor even mused, “I wonder if this is the end of MTurk research?” (It wasn’t).

To tackle this problem, Rice Business professor Mikki Hebl joined colleagues Carlos Moreno and Christy Nittrouer of Rice University along with several other colleagues to highlight the value of other research methods. Four alternatives – field experiments, archival data, observations and big data – represent smart alternatives to overreliance on online surveys. These methods also have the advantage of challenging academics to venture outside of their laboratories and examine real people and real data in the real world.

Field experiments have been around for decades. But their value is hard to overestimate. Unlike online studies, field experiments enhance the role of context, especially in settings that are largely uncontrolled. It’s hard to fake a field experiment in order to create positive results since each one costs a considerable time and money.

And field experiments can yield real-life results with remarkable implications for society at large. Consider one experiment among 56 middle schools in New Jersey, which found that spreading anti-conflict norms was hugely successful in reducing the need for disciplinary action. Such studies have an impact well beyond what could be achieved with a simple online survey.

The best way to get started with a good field experiment, Hebl and her colleagues wrote, is for researchers to think about natural field settings to which they have access, either personally or by leveraging their networks. Then, researchers should think about starting with the variables critical for any given setting and which they would most like to manipulate to observe the outcome. When choosing variables, it’s helpful to start by thinking about what variable might have conditions leading to the greatest degree of behavior change if introduced into the setting.

Archival data is another excellent way to work around the limitations of online surveys, the researchers argue. These data get around some of the critical drawbacks of field research, including problems around how findings apply in a more general way. Archival data, especially in the form of state or national level data sets, provide information and insight into a large, diverse set of samples that are more representative of the general population than online studies.

Archival data can also help answer questions that are either longitudinal or multilevel in nature, which can be particularly tricky or even impossible to capture with data collected by any single research team. As people spend increasing amounts of time on social media, the internet also serves as a source of newer forms of archival data that can lend unique insights into individuals’ thoughts, attitudes, and behaviors over time.

With every passing year, technology becomes increasingly robust and adept at collecting massive amounts of data on an endless variety of human behavior. For the scientists who research social and personality psychology, the term “big data” refers not only to very large sets of data but also to the tools and techniques that are used to analyze it. The three defining properties of Big Data in this context include the speed of data processing and collection, the vast amount of data being analyzed and the sheer variety of data available.

By using big data, social scientists can generate research based on various conditions, as well as collect data in natural settings. Big data also offers the opportunity to consolidate information from huge and highly diverse stores of data. This technology has many applications, including psychological assessments and improving security in airports and other transportation hubs. In future research, Hebl and her team noted, researchers will likely leverage big data and its applications to detect our unconscious emotions.

Big data, archival information and field studies can all be used in conjunction with each other to maximize the fidelity of research. But researchers shouldn’t forget even more old-fashioned techniques, including the oldest: keen observation. With observation, there are often very few, if any, manipulations and the goal is simply to systematically record the way people behave.

Researchers – and the managers who make decisions based on their findings – should consider the advantages of old-style, often underused methodologies, Hebl and her colleagues argue. Moving beyond the college laboratory and digital data survey-collection platforms and into the real world offers some unparalleled advantages to science. For the managers whose stock prices may hinge on this science, it’s worth knowing – and understanding – how your all-important data was gathered.

------

This article originally ran on Rice Business Wisdom and is based on research from Mikki Hebl, the Martha and Henry Malcolm Lovett Professor of psychology at Rice University, and Carlos Moreno and Christy Nittrouer, who are graduate students at Rice University. Additional researchers include Ho Kwan Cheung, Eden B. King, and Hannah Markellis of George Mason University.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Houston researchers report promising first in-human trial for implantable cancer therapy

cancer breakthrough

When it comes to cancer remedies, the treatment can be as challenging for the body as its cause. But what if immunotherapy could be localized? That’s precisely what a Houston team may soon make a reality.

Rice University researchers, in partnership with MD Anderson Cancer Center, recently published their findings from the first in-human trial of an implantable cancer-fighting treatment in the journal Clinical Cancer Research. The paper details testing of AVB-001, encapsulated cells engineered to release interleukin-2 (IL-2)—a naturally occurring signaling protein that boosts immunity—in the peritoneal cavities of 14 patients. The goal is to avoid the toxicity usually experienced with less targeted treatments, as well as find a solution to IL-2s’ abbreviated half-lives.

“Traditional IL-2 therapy has shown potent antitumor activity, but its clinical use has been limited by severe side effects and delivery challenges,” Omid Veiseh, director of the Rice Biotech Launch Pad, professor of bioengineering at Rice and a senior author on the study, said in a press release. “This platform allows us to localize and sustain cytokine exposure directly where tumors reside while minimizing systemic toxicity.”

Serous ovarian carcinoma is especially well-suited to the use of AVB-001 because it tends to spread throughout the abdomen. After a minimally invasive laparoscopic procedure, patients implanted with the cells were noted to tolerate the treatment well. Half of the enrolled patients’ cancer was stabilized, with several among them reporting extended signs of benefit. No maximum tolerated dose was reached and there were no life-threatening events tied to the study.

If that sounds like less-than-earth-shaking results, this is only the beginning. The capsules were implanted for about one week because IL-2 activity drops off after that. The researchers now know that further testing should include either higher levels, repeated doses, or a combination thereof, in order to create stronger advances.

The team has already made early headway on this next step. Preclinical studies in nonhuman primates were not only tolerated well, but without added toxicity, the apes had consistent pharmacological effects.

“This is a foundational step,” Veiseh explained. “We now have evidence that the platform is safe, biologically active and potentially scalable. The next phase is optimizing dosing and exploring combination therapies to unlock its full clinical potential.”

The combination would also include a checkpoint inhibitor, which might improve AVB-001’s tumor-fighting power. “What is exciting is that we are not just delivering a drug, we are programming a microenvironment,” added Dr. Amir Jazaeri, professor of gynecologic oncology at MD Anderson, member of the Rice Biotech Launch Pad’s clinical advisory board and a senior author on the study. “This opens the door to combination strategies that could amplify immune responses in ways that have not been feasible before.”

Houston startup raises $6M to scale home-based healthcare platform

fresh funding

As healthcare systems race to expand care beyond hospitals and into the home, investors are placing bigger bets on the infrastructure needed to make that shift possible.

This month, Rosarium Health announced it has raised $6 million in seed funding led by Kalos Ventures, with participation from ResilienceVC, Rock Health Capital, Symphonic Capital, Black Tech Nations Ventures and others.

The investment will help the Houston-based startup continue to build its platform, which features a national network of 800-plus clinicians and 3,000-plus contractors to coordinate home accessibility upgrades and modifications for seniors and people living with disabilities.

For founder and CEO Cameron Carter, the company’s mission grew out of firsthand caregiving experiences.

“From my own personal caregiving experiences, I realized that the benefits exist on paper, but not in reality,” Carter said in a news release. “Families are being left to figure out the paperwork and installations all on their own, which shouldn’t be how this works.”

While Medicare Advantage and Medicaid plans have expanded coverage for home-based services and accessibility modifications, the logistics behind delivering those services often remain fragmented.

Rosarium’s platform coordinates the entire process, from clinical assessments and referrals to contractor management, documentation, reimbursement and installation.

“A clinician can document that a home isn’t safe and a plan can approve a benefit, but there’s no one that’s responsible for making sure the work actually gets done,” Carter says. “We built the missing piece.”

The company was founded in 2021 as Rose Health and was a 2023 participant in the Texas Medical Center’s Accelerator for HealthTech program. It has scaled quickly, building a network of more than 800 clinicians and 3,000 contractors across 34 states.

Rosarium is currently in-network for 1.2 million Medicare and Medicaid lives, with projected coverage expected to reach nearly 4 million by the end of the year, according to the release.

“We’re excited to back Cameron because he and the team at Rosarium are building the infrastructure healthcare needs right now to make the home a safe and comfortable place of care,” Kate Ballinger, investor at Kalos Ventures, added in the release.

As part of the recent investment, Ballinger will join Rosarium’s board of directors.

With eyes on the future, Rosarium plans to grow its partnerships with Medicaid and Medicare Advantage plans, including CalViva and Community Health Plan of Imperial Valley, strengthening its presence in California while expanding access to underserved communities.

Additionally, Carter predicts that home-based healthcare will be part of a broader transformation happening across the industry.

“There’s a growing recognition that health outcomes are shaped by what happens in the home,” he said in the release. “The future of healthcare isn’t just treating people after something goes wrong. It’s creating environments that help prevent those problems in the first place.”